Alembic Pharma gains after Rhizen enters into agreement for Dual PI3K-delta gamma Inhibitor

10 Dec 2015 Evaluate

Alembic Pharmaceuticals is currently trading at Rs. 675.05, up by 6.45 points or 0.96% from its previous closing of Rs. 668.60 on the BSE.

The scrip opened at Rs. 680.00 and has touched a high and low of Rs. 688.00 and Rs. 670.00 respectively. So far 3,643 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 791.70 on 15-Jul-2015 and a 52 week low of Rs. 381.90 on 26-Feb-2015.

Last one week high and low of the scrip stood at Rs. 702.40 and Rs. 666.00 respectively. The current market cap of the company is Rs. 12,725.00 crore.

The promoters holding in the company stood at 74.13% while Institutions and Non-Institutions held 12.60% and 13.28% respectively.

Alembic Pharmaceuticals’ associate company - Rhizen Pharmaceuticals S.A., has entered into an exclusive, worldwide license agreement with Novartis for the development and commercialization of Rhizen’s, inhaled dual PI3K-delta gamma inhibitor and its closely related compounds for various indications.

Under the terms of the agreement, Rhizen will receive an upfront payment and is eligible to receive development, regulatory and sales milestones payments. In addition, Rhizen is also eligible to receive tiered royalties on annual nets sales.

The lead compound is a novel, potent, and selective dual PI3K-delta gamma inhibitor with demonstrated anti-inflammatory and immuno-modulatory activity in pre-clinical systems and models representative of respiratory diseases. With a favorable ADME and PK profile and high therapeutic index in animals, the inhaled dual PI3K-delta gamma inhibitor holds promise in the treatment of human airway disorders.


Alembic Pharma Share Price

899.90 -2.30 (-0.25%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×